Your browser doesn't support javascript.
Advantages and disadvantages of disulfiram coadministered with popular addictive substances.
Kleczkowska, Patrycja; Sulejczak, Dorota; Zaremba, Malgorzata.
  • Kleczkowska P; Department of Pharmacodynamics, Centre for Preclinical Research (CBP), Medical University of Warsaw, 02-097, Warsaw, Poland; Military Institute of Hygiene and Epidemiology, 01-163, Warsaw, Poland. Electronic address: hazufiel@wp.pl.
  • Sulejczak D; Department of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 02-106, Warsaw, Poland.
  • Zaremba M; Military Institute of Hygiene and Epidemiology, 01-163, Warsaw, Poland; Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research (CBP), Medical University of Warsaw, 02-097, Warsaw, Poland.
Eur J Pharmacol ; 904: 174143, 2021 Aug 05.
Article in English | MEDLINE | ID: covidwho-1487708
ABSTRACT
Disulfiram (DSF) is a well-known anti-alcohol agent that inhibits aldehyde dehydrogenase and results in extreme 'hangover' symptoms when consumed with alcohol. This drug, however, has been suggested as useful in other forms of drug addiction due to its beneficial potential in both drug abuse reduction and withdrawal. However, among other drugs used in alcohol dependence, it carries the greatest risk of pharmacological interactions. Concomitant use of DSF and central nervous system stimulants usually leads to harmful, undesirable effects. To date, there is still limited data regarding the detailed safety profile of DSF as a concomitant drug. In this review article, we outline the current state of knowledge about DSF, its broad pharmacological action, as well as therapeutic effects, with a particular emphasis on the molecular understanding of its potential pharmacodynamic interactions with common addictive substances (e.g., alcohol, cocaine, cannabinoids, opioids) supported by relevant examples.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Substance-Related Disorders / Disulfiram / Acetaldehyde Dehydrogenase Inhibitors Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Eur J Pharmacol Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Substance-Related Disorders / Disulfiram / Acetaldehyde Dehydrogenase Inhibitors Type of study: Prognostic study Limits: Animals / Humans Language: English Journal: Eur J Pharmacol Year: 2021 Document Type: Article